British Columbia is implementing a new policy that requires witnesses for individuals prescribed a safer supply of drugs. This move aims to prevent the diversion of prescribed opioids, which have been a significant concern in the province. The program, launched in March 2020 during the peak of the COVID-19 pandemic, initially provided take-home safer supply to patients. However, recent revelations of pharmacies offering incentives to clients and the diversion of prescribed opioids into the hands of organized criminals led to a shift in the program's approach.
The new guidelines mandate that all patients receiving prescribed safer supply must have their consumption witnessed by a medical professional or pharmacist. This change was announced by B.C. Health Minister Josie Osborne, who emphasized the importance of ensuring that prescribed alternatives reach those who need them. She stated that this approach is crucial for separating individuals from the illicit drug supply and keeping them alive to access care and treatment.
Despite the program's positive impact on reducing overdose deaths and overdoses, as evidenced by a peer-reviewed study, it has faced criticism. Some doctors argue that the witnessed-only model interferes with medical decision-making and doesn't support individuals in breaking free from their drug dealers. The debate surrounding this policy highlights the complex nature of addressing drug addiction and the challenges of balancing public health and individual autonomy.
